Corporate News 19-Oct-23
Biocon Biologics appoints Kedar Upadhye as CFO
With effect from 31 October 2023
Biocon Biologics announced the appointment of Kedar Upadhye as the new Chief Financial Officer (CFO) and the Company's current CFO, MB Chinappa, will transition to take on a strategic finance role at Biocon Group. These leadership changes will be effective 31 October 2023.
Previous News
Biocon Biologics signs distribution agreement with Sandoz
( Corporate News - 22-Dec-23 19:57 )
Biocon Biologics divests its non-crore branded formulations biz in India
( Corporate News - 10-Nov-23 12:06 )
Biocon Biologics concludes integration of acquired biosimilar biz in 120 countries
( Corporate News - 18-Dec-23 18:06 )
Biocon Biologics completes integration of acquired biosimilars business from Viatris
( Corporate News - 06-Sep-23 18:21 )
Biocon Biologics appoints Kedar Upadhye as CFO
( Corporate News - 19-Oct-23 18:52 )
Biocon Biologics set to introduce YESAFILI®, a proposed biosimilar to EYLEA® in Canadian market
( Corporate News - 04-Mar-24 09:30 )
Biocon Biologics receives GMP certifications for its Indian and Malaysian manufacturing units
( Corporate News - 24-Jun-24 09:01 )
Biocon Biologics receives UDFDA approval for Yesafili™
( Corporate News - 21-May-24 09:13 )
Other Stories
GRP schedules AGM
01-Jul-24 20:01
Mahindra & Mahindra domestic PV sales jump 23% in June
01-Jul-24 20:01
Vipul Organics constructs new factory in Ambernath, Maharashtra
01-Jul-24 20:00
Greaves Engineering launches range of new CPCB IV+ Compliant Gensets
01-Jul-24 19:41
Godrej Properties to develop 7-acre land in Thanisandra, North Bengaluru
01-Jul-24 19:39
Rama Phosphates AGM scheduled
01-Jul-24 19:34
Take Solutions to convene AGM
01-Jul-24 19:34
Fischer Medical Ventures partners with Singapore-based Nervotec
01-Jul-24 19:29
NIIT appoints Pankaj Jathar as Chief Executive Officer
01-Jul-24 19:27
Dynacons Systems recognized as India's Leading Listed ESG Entities 2024
01-Jul-24 19:26
Back
Top
